2nd REsolution Consortium Meeting


On 20 June 2022, the REsolution consortium held its second consortium meeting, which was the first one in person since the project started. The event took place at CeMM with 20 participants coming from different countries.

REsolution scientists summarized the data generated on the collection and annotation of human genetic variants for SLCs and associated phenotypes. They also re-aligned on the strategies to characterize selected variants and perform deep mutational scanning studies on SLCs involved in human diseases. Finally, they discussed the interpretation of variant effects based on structural and functional information and compared to predicted effects by Variant Effect Predictors.

 More News


The Department of Pharmaceutical Sciences is looking for a dedicated Third-Party Funding Officer for the administrative coordination of externally...


The eTRANSAFE consortium members got together on 20-21 October for the second face-to-face meeting of the year. The event also featured the 2nd...


The consortia meetings of REsolution and RESOLUTE took place in Berlin. The event, hosted by Bayer, gathered 60 international participants. On October...